Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
|Articles|January 16, 2013
Equipment and Processing Report
- Equipment and Processing Report-01-16-2013
- Volume 0
- Issue 0
January 2013 Editor's Picks: Products from Cole-Parmer and Yokogawa
Products from Cole-Parmer and Yokogawa
Cole-Parmer
Portable freezer offers secure, low-temperature transport
Yokogawa
Dual bent-tube coriolis meter measures liquid and gas flow at low rates
Yokogawa’s RotaMass LR is, according to the company, the world’s smallest dual bent-tube coriolis meter, and it is designed for accurate and stable measurement of fluids at low flow rates. The meter measures mass flow of gases or liquids from 0–40 kg/h, with an accuracy of +/- 0.15% for liquids and +/- 0.5% for gases. The dual bent-tube design decouples the core-measuring element from process vibration that can cause fluctuating zero stability and decrease measurement accuracy. It is also insensitive to fluctuations in ambient temperature. Although tubes with a smaller surface area normally make it more difficult to measure temperature, the RotaMass LR solves this problem by using an inline temperature sensor that ensures exact and fast measurements in process temperatures ranging from −50 to +150 °C.
Articles in this issue
over 13 years ago
Improving Tablet-Press Tooling Maintenance and Storageover 13 years ago
Logging the Cold Chainover 13 years ago
Using Micronization to Reduce API Particle SizeRelated to this article
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.